' Akciju kurss '

Datums	China Resources Medical Holdings Company Akciju kurss
25.09.2024.	3,18 undefined
24.09.2024.	3,20 undefined
23.09.2024.	3,08 undefined
20.09.2024.	3,12 undefined
19.09.2024.	3,14 undefined
17.09.2024.	3,09 undefined
16.09.2024.	3,09 undefined
13.09.2024.	3,16 undefined
12.09.2024.	3,18 undefined
11.09.2024.	3,06 undefined
10.09.2024.	3,06 undefined
9.09.2024.	3,07 undefined
5.09.2024.	3,11 undefined
4.09.2024.	3,17 undefined
3.09.2024.	3,17 undefined
2.09.2024.	3,18 undefined
30.08.2024.	3,23 undefined
29.08.2024.	3,26 undefined
28.08.2024.	3,16 undefined

Datums	China Resources Medical Holdings Company Apgrozījums	China Resources Medical Holdings Company EBIT	China Resources Medical Holdings Company Peļņa
2026e	12,04 miljardi undefined	1,27 miljardi undefined	841,00 milj. undefined
2025e	11,42 miljardi undefined	1,18 miljardi undefined	768,73 milj. undefined
2024e	10,89 miljardi undefined	1,05 miljardi undefined	639,52 milj. undefined
2023	10,11 miljardi undefined	1,02 miljardi undefined	257,68 milj. undefined
2022	7,90 miljardi undefined	593,70 milj. undefined	265,86 milj. undefined
2021	4,45 miljardi undefined	354,33 milj. undefined	417,92 milj. undefined
2020	2,75 miljardi undefined	300,37 milj. undefined	310,13 milj. undefined
2019	2,12 miljardi undefined	516,91 milj. undefined	390,87 milj. undefined
2018	2,06 miljardi undefined	537,35 milj. undefined	430,90 milj. undefined
2017	1,88 miljardi undefined	460,93 milj. undefined	421,03 milj. undefined
2016	1,53 miljardi undefined	289,12 milj. undefined	-1,51 miljardi undefined
2015	1,37 miljardi undefined	230,19 milj. undefined	167,05 milj. undefined
2014	1,21 miljardi undefined	256,29 milj. undefined	230,05 milj. undefined
2013	887,40 milj. undefined	199,10 milj. undefined	90,00 milj. undefined
2012	758,00 milj. undefined	164,60 milj. undefined	101,10 milj. undefined
2011	509,50 milj. undefined	90,90 milj. undefined	48,10 milj. undefined
2010	394,10 milj. undefined	67,50 milj. undefined	42,80 milj. undefined

	Apgrozījums	EBIT	Peļņa
2010	394,10 milj. CNY	67,50 milj. CNY	42,80 milj. CNY
2011	509,50 milj. CNY	90,90 milj. CNY	48,10 milj. CNY
2012	758,00 milj. CNY	164,60 milj. CNY	101,10 milj. CNY
2013	887,40 milj. CNY	199,10 milj. CNY	90,00 milj. CNY
2014	1,21 miljardi CNY	256,29 milj. CNY	230,05 milj. CNY
2015	1,37 miljardi CNY	230,19 milj. CNY	167,05 milj. CNY
2016	1,53 miljardi CNY	289,12 milj. CNY	-1,51 miljardi CNY
2017	1,88 miljardi CNY	460,93 milj. CNY	421,03 milj. CNY
2018	2,06 miljardi CNY	537,35 milj. CNY	430,90 milj. CNY
2019	2,12 miljardi CNY	516,91 milj. CNY	390,87 milj. CNY
2020	2,75 miljardi CNY	300,37 milj. CNY	310,13 milj. CNY
2021	4,45 miljardi CNY	354,33 milj. CNY	417,92 milj. CNY
2022	7,90 miljardi CNY	593,70 milj. CNY	265,86 milj. CNY
2023	10,11 miljardi CNY	1,02 miljardi CNY	257,68 milj. CNY
2024e	10,89 miljardi CNY	1,05 miljardi CNY	639,52 milj. CNY
2025e	11,42 miljardi CNY	1,18 miljardi CNY	768,73 milj. CNY
2026e	12,04 miljardi CNY	1,27 miljardi CNY	841,00 milj. CNY

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0,39	0,51	0,76	0,89	1,21	1,37	1,53	1,88	2,06	2,12	2,75	4,45	7,90	10,11	10,89	11,42	12,04
-	29,19	48,92	17,02	35,96	13,76	11,66	22,52	9,70	2,72	30,02	61,71	77,67	27,92	7,75	4,86	5,43
23,35	23,97	24,27	23,90	24,63	23,98	26,50	35,59	36,72	36,03	23,13	20,98	16,52	18,85	-	-	-
0,09	0,12	0,18	0,21	0,30	0,33	0,41	0,67	0,76	0,76	0,64	0,93	1,31	1,91	0	0	0
0,07	0,09	0,16	0,20	0,26	0,23	0,29	0,46	0,54	0,52	0,30	0,35	0,59	1,02	1,05	1,18	1,27
17,01	17,68	21,64	22,44	21,23	16,76	18,86	24,51	26,08	24,40	10,91	7,96	7,51	10,11	9,63	10,37	10,56
42,00	48,00	101,00	90,00	230,00	167,00	-1506,00	421,00	430,00	390,00	310,00	417,00	265,00	257,00	639,00	768,00	841,00
-	14,29	110,42	-10,89	155,56	-27,39	-1001,80	-127,95	2,14	-9,30	-20,51	34,52	-36,45	-3,02	148,64	20,19	9,51
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0,60	0,60	0,60	0,58	0,83	0,82	0,90	1,28	1,27	1,25	1,26	1,26	1,26	1,26	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022

0,32	0,35	0,17	1,28	1,07	1,01	1,19	1,59	1,90	2,28	2,97	2,64	3,42
0,02	0,02	0,08	0,08	0,09	0,14	0,26	0,35	0,51	0,63	0,64	0,79	1,51
0,04	0,08	0,06	0,07	0,08	0,07	0,13	0,10	0,02	0,21	0,29	0,17	1,06
22,30	23,20	35,10	31,10	33,83	42,32	50,24	38,60	77,89	62,12	142,04	185,08	367,48
3,10	8,90	10,10	10,30	15,69	27,23	25,24	27,46	29,46	19,59	102,89	141,26	399,51
0,41	0,49	0,37	1,47	1,29	1,29	1,65	2,11	2,53	3,20	4,15	3,92	6,77
0,09	0,11	0,12	0,12	0,14	0,15	0,26	0,26	0,26	0,34	1,05	2,12	5,42
0	0	0	0	0	0,15	0,68	0,67	0,67	0,63	0,75	1,93	1,57
22,30	36,10	48,50	51,20	68,99	109,42	113,00	160,88	161,66	136,04	128,41	58,90	60,25
0,11	0,16	0,32	0,32	0,36	0,40	2,13	2,11	2,10	2,04	1,35	0,08	0,07
0	0	0	0	0	0	1,46	1,46	1,46	1,46	1,47	2,28	3,74
31,20	346,10	162,50	158,90	151,79	147,40	143,72	140,35	136,97	76,27	76,46	86,45	191,86
0,25	0,64	0,66	0,65	0,72	0,96	4,79	4,80	4,79	4,68	4,82	6,54	11,05
0,66	1,13	1,02	2,12	2,01	2,26	6,45	6,91	7,32	7,87	8,96	10,47	17,82

130,60	165,60	140,60	0,20	0,17	0,17	0,27	0,27	0,27	0,27	0,27	0,27	0,27
0	0	0	1,54	1,50	1,38	6,37	6,30	6,18	5,99	5,88	5,79	0
0,15	0,43	0,34	0,07	0,30	0,50	-1,01	-0,60	-0,19	0,21	0,53	0,96	9,51
0	0	0	0	0	6,76	16,98	-0,54	-15,70	-17,03	-21,27	-14,66	0
0	0	0	0	0	0	-16,27	-16,27	0	0	0	0	0
0,28	0,59	0,49	1,62	1,80	1,89	5,35	5,68	5,97	6,19	6,39	6,73	9,51
0,08	0,09	0,12	0,12	0,17	0,21	0,24	0,26	0,22	0,24	0,56	0,83	1,73
10,30	13,10	18,80	17,80	17,06	23,15	59,18	92,17	106,24	106,39	279,03	435,53	0
0,06	0,03	0,05	0,06	0,08	0,16	0,45	0,46	0,46	0,45	0,66	0,49	2,04
0	0	0	0	0	0	0	0,17	0,49	0,58	0,68	1,67	0
0	0,20	0,01	0,20	0	0	0	0	0	0,01	0,02	0,02	1,35
0,14	0,33	0,20	0,40	0,27	0,39	0,75	0,98	1,28	1,38	2,21	3,44	5,12
0,20	0	0,23	0	0	0	0	0	0	0,01	0,05	0,04	1,05
0	0	0	0	0	0	318,88	317,63	316,37	317,83	317,62	95,25	71,32
12,60	10,50	8,60	5,30	3,23	2,92	19,58	18,39	16,02	18,12	51,16	41,92	915,48
0,21	0,01	0,24	0,01	0,00	0,00	0,34	0,34	0,33	0,35	0,42	0,18	2,04
0,36	0,34	0,44	0,41	0,28	0,39	1,09	1,31	1,61	1,73	2,62	3,62	7,16
0,64	0,93	0,93	2,03	2,08	2,28	6,44	6,99	7,58	7,92	9,01	10,35	16,67

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
65,00	78,00	147,00	143,00	316,00	247,00	-1452,00	559,00	588,00	541,00	418,00	270,00	242,00
17,00	17,00	32,00	33,00	35,00	41,00	47,00	63,00	69,00	63,00	113,00	182,00	332,00
0	0	0	0	0	0	0	0	0	0	0	0	0
-14,00	-48,00	-33,00	-41,00	-34,00	-86,00	-107,00	-76,00	-276,00	-226,00	211,00	40,00	-111,00
0,00	0,01	0,02	0,04	-0,04	0,03	1,74	-0,09	-0,05	-0,01	-0,10	0,22	0,16
0	18,00	23,00	32,00	0	0	0	1,00	6,00	16,00	14,00	19,00	46,00
11,00	20,00	27,00	41,00	59,00	80,00	71,00	60,00	162,00	163,00	98,00	135,00	135,00
70,00	62,00	166,00	169,00	274,00	231,00	223,00	459,00	334,00	366,00	643,00	710,00	626,00
-17,00	-34,00	-28,00	-21,00	-36,00	-32,00	-42,00	-34,00	-57,00	-36,00	-209,00	-227,00	-252,00
-328,00	-36,00	-102,00	-841,00	360,00	29,00	120,00	-545,00	355,00	157,00	60,00	-1936,00	57,00
-310,00	-1,00	-74,00	-820,00	397,00	61,00	162,00	-510,00	413,00	193,00	269,00	-1708,00	310,00
0	0	0	0	0	0	0	0	0	0	0	0	0
200,00	0	32,00	-41,00	0	0	0	180,00	303,00	73,00	131,00	966,00	143,00
0	0	-0,20	1,39	-0,18	-0,02	0	-0,10	-0,21	0	0	0	0
298,00	230,00	-282,00	971,00	-421,00	-48,00	-98,00	-104,00	-44,00	-40,00	-7,00	845,00	-33,00
98,00	230,00	-114,00	-379,00	-1,00	7,00	-15,00	-112,00	-15,00	17,00	-23,00	-29,00	-47,00
0	0	0	0	-44,00	-32,00	-83,00	-69,00	-118,00	-131,00	-115,00	-91,00	-129,00
40,00	256,00	-217,00	288,00	209,00	210,00	247,00	-192,00	647,00	482,00	695,00	-377,00	653,00
52,90	28,10	138,30	148,40	237,96	199,53	181,34	425,04	276,54	329,69	434,14	483,17	373,72
0	0	0	0	0	0	0	0	0	0	0	0	0

China Resources Medical Holdings Company Brutomarža	China Resources Medical Holdings Company Peļņas marge	China Resources Medical Holdings Company EBIT marža	China Resources Medical Holdings Company Peļņas marge
2026e	18,86 %	10,56 %	6,99 %
2025e	18,86 %	10,37 %	6,73 %
2024e	18,86 %	9,63 %	5,87 %
2023	18,86 %	10,12 %	2,55 %
2022	16,53 %	7,51 %	3,36 %
2021	20,99 %	7,97 %	9,40 %
2020	23,14 %	10,92 %	11,27 %
2019	36,04 %	24,44 %	18,48 %
2018	36,74 %	26,09 %	20,92 %
2017	35,59 %	24,55 %	22,42 %
2016	26,53 %	18,86 %	-98,31 %
2015	24,02 %	16,77 %	12,17 %
2014	24,68 %	21,25 %	19,07 %
2013	23,97 %	22,44 %	10,14 %
2012	24,38 %	21,72 %	13,34 %
2011	24,08 %	17,84 %	9,44 %
2010	23,57 %	17,13 %	10,86 %

	Brutomarža	EBIT marža	Peļņas marge
2010	23,57 %	17,13 %	10,86 %
2011	24,08 %	17,84 %	9,44 %
2012	24,38 %	21,72 %	13,34 %
2013	23,97 %	22,44 %	10,14 %
2014	24,68 %	21,25 %	19,07 %
2015	24,02 %	16,77 %	12,17 %
2016	26,53 %	18,86 %	-98,31 %
2017	35,59 %	24,55 %	22,42 %
2018	36,74 %	26,09 %	20,92 %
2019	36,04 %	24,44 %	18,48 %
2020	23,14 %	10,92 %	11,27 %
2021	20,99 %	7,97 %	9,40 %
2022	16,53 %	7,51 %	3,36 %
2023	18,86 %	10,12 %	2,55 %
2024e	18,86 %	9,63 %	5,87 %
2025e	18,86 %	10,37 %	6,73 %
2026e	18,86 %	10,56 %	6,99 %

Datums	China Resources Medical Holdings Company Apgrozījums uz vienu akciju	China Resources Medical Holdings Company EBIT uz vienu akciju	China Resources Medical Holdings Company Peļņa uz vienu akciju
2026e	9,34 undefined	0 undefined	0,65 undefined
2025e	8,86 undefined	0 undefined	0,60 undefined
2024e	8,45 undefined	0 undefined	0,50 undefined
2023	7,99 undefined	0,81 undefined	0,20 undefined
2022	6,26 undefined	0,47 undefined	0,21 undefined
2021	3,52 undefined	0,28 undefined	0,33 undefined
2020	2,18 undefined	0,24 undefined	0,25 undefined
2019	1,69 undefined	0,41 undefined	0,31 undefined
2018	1,62 undefined	0,42 undefined	0,34 undefined
2017	1,47 undefined	0,36 undefined	0,33 undefined
2016	1,70 undefined	0,32 undefined	-1,67 undefined
2015	1,67 undefined	0,28 undefined	0,20 undefined
2014	1,45 undefined	0,31 undefined	0,28 undefined
2013	1,54 undefined	0,35 undefined	0,16 undefined
2012	1,26 undefined	0,27 undefined	0,17 undefined
2011	0,85 undefined	0,15 undefined	0,08 undefined
2010	0,65 undefined	0,11 undefined	0,07 undefined

	Apgrozījums uz vienu akciju	EBIT uz vienu akciju	Peļņa uz vienu akciju
2010	0,65 CNY	0,11 CNY	0,07 CNY
2011	0,85 CNY	0,15 CNY	0,08 CNY
2012	1,26 CNY	0,27 CNY	0,17 CNY
2013	1,54 CNY	0,35 CNY	0,16 CNY
2014	1,45 CNY	0,31 CNY	0,28 CNY
2015	1,67 CNY	0,28 CNY	0,20 CNY
2016	1,70 CNY	0,32 CNY	-1,67 CNY
2017	1,47 CNY	0,36 CNY	0,33 CNY
2018	1,62 CNY	0,42 CNY	0,34 CNY
2019	1,69 CNY	0,41 CNY	0,31 CNY
2020	2,18 CNY	0,24 CNY	0,25 CNY
2021	3,52 CNY	0,28 CNY	0,33 CNY
2022	6,26 CNY	0,47 CNY	0,21 CNY
2023	7,99 CNY	0,81 CNY	0,20 CNY
2024e	8,45 CNY	0 CNY	0,50 CNY
2025e	8,86 CNY	0 CNY	0,60 CNY
2026e	9,34 CNY	0 CNY	0,65 CNY

	Akciju skaits
2010	602,70 milj. Aktien
2011	602,70 milj. Aktien
2012	602,70 milj. Aktien
2013	575,80 milj. Aktien
2014	830,87 milj. Aktien
2015	819,35 milj. Aktien
2016	901,56 milj. Aktien
2017	1,28 miljardi Aktien
2018	1,27 miljardi Aktien
2019	1,25 miljardi Aktien
2020	1,26 miljardi Aktien
2021	1,26 miljardi Aktien
2022	1,26 miljardi Aktien
2023	1,26 miljardi Aktien
2024e	1,26 miljardi Aktien
2025e	1,26 miljardi Aktien
2026e	1,26 miljardi Aktien

Datums	China Resources Medical Holdings Company Dividende
2026e	0,04 undefined
2025e	0,04 undefined
2024e	0,04 undefined
2023	0,04 undefined
2022	0,12 undefined
2021	0,09 undefined
2020	0,10 undefined
2019	0,12 undefined
2018	0,11 undefined
2017	0,06 undefined
2016	0,12 undefined
2015	0,05 undefined
2014	0,07 undefined

	Dividende	Dividende (prognoze)
2010	0 CNY	0 CNY
2011	0 CNY	0 CNY
2012	0 CNY	0 CNY
2013	0 CNY	0 CNY
2014	0,07 CNY	0 CNY
2015	0,05 CNY	0 CNY
2016	0,12 CNY	0 CNY
2017	0,06 CNY	0 CNY
2018	0,11 CNY	0 CNY
2019	0,12 CNY	0 CNY
2020	0,10 CNY	0 CNY
2021	0,09 CNY	0 CNY
2022	0,12 CNY	0 CNY
2023	0,04 CNY	0 CNY
2024e	0 CNY	0,04 CNY
2025e	0 CNY	0,04 CNY
2026e	0 CNY	0,04 CNY

Datums	China Resources Medical Holdings Company Izplatīšanas likme
2026e	43,27 %
2025e	46,69 %
2024e	41,69 %
2023	41,43 %
2022	56,96 %
2021	26,67 %
2020	40,66 %
2019	38,52 %
2018	32,36 %
2017	19,16 %
2016	-7,18 %
2015	24,52 %
2014	24,20 %
2013	41,43 %
2012	41,43 %
2011	41,43 %
2010	41,43 %

	Izplatīšanas likme
2010	41,43 %
2011	41,43 %
2012	41,43 %
2013	41,43 %
2014	24,20 %
2015	24,52 %
2016	-7,18 %
2017	19,16 %
2018	32,36 %
2019	38,52 %
2020	40,66 %
2021	26,67 %
2022	56,96 %
2023	41,43 %
2024e	41,69 %
2025e	46,69 %
2026e	43,27 %

Datums	EPS-prognoze	EPS-Faktiskais	Ziņojuma ceturksnis
31.12.2018.	0,16	0,18 (10,29 %)	2018 Q4
30.06.2018.	0,15	0,16 (4,58 %)	2018 Q2
30.06.2017.	0,12	0,18 (47,88 %)	2017 Q2
30.06.2016.	0,17	0,16 (-7,73 %)	2016 Q2
31.12.2015.	0,17	0,17 (-4,84 %)	2015 Q4

%	Nosaukums	Akcijas	Izmaiņas	Datums
5,02656 %	First Sentier Investors (Hong Kong) Limited	64 757 166	-467 000	12.04.2024.
36,81744 %	China Resources Co Ltd	474 319 516	0	31.12.2022.
3,42030 %	British Columbia Investment Management Corp.	44 063 720	5 307 078	31.03.2023.
2,79258 %	Norges Bank Investment Management (NBIM)	35 976 873	10 294 190	31.12.2023.
1,47532 %	The Vanguard Group, Inc.	19 006 588	0	31.03.2024.
1,29939 %	Dimensional Fund Advisors, L.P.	16 740 000	200 000	29.02.2024.
1,10572 %	BlackRock Institutional Trust Company, N.A.	14 245 000	-22 000	31.03.2024.
1,04929 %	Bosera Asset Management Co., Ltd.	13 518 000	3 299 000	31.12.2023.
0,94663 %	China Merchants Fund Management Co. Ltd.	12 195 500	8 981 500	30.06.2023.
0,83514 %	FIL Investment Management (Hong Kong) Limited	10 759 163	10 759 163	29.02.2024.
0,37567 %	APG Asset Management N.V.	4 839 763	3 685 428	30.09.2023.
0,31192 %	Huisheng Fund Management Co., Ltd.	4 018 500	4 018 500	30.06.2023.
0,28914 %	BlackRock Advisors (UK) Limited	3 725 000	-59 000	31.03.2024.
0,27482 %	Truvalue Asset Management Co., Ltd.	3 540 500	-56 500	31.12.2023.
0,25848 %	Tianhong Asset Management Co., Ltd.	3 330 000	-159 000	31.12.2023.
0,25417 %	Taikang Asset Management Co., Ltd.	3 274 500	-170 000	31.12.2023.
0,25099 %	California State Teachers Retirement System	3 233 500	58 500	30.06.2023.
0,22988 %	American Century Investment Management, Inc.	2 961 500	109 000	31.03.2024.
0,17981 %	Wellington Management Company, LLP	2 316 433	-1 437 500	30.09.2023.
0,17127 %	State Street Global Advisors (US)	2 206 500	-37 500	31.03.2024.
0,17077 %	BOCOM International Asset Management Limited	2 200 000	2 200 000	30.06.2023.
0,14539 %	Dimensional Fund Advisors, Ltd.	1 873 000	228 500	29.02.2024.
0,13776 %	Cheng (Libing)	1 774 746	0	27.02.2023.
0,13324 %	BlackRock Fund Management Co., Ltd.	1 716 500	1 716 500	30.06.2023.
0,12013 %	E Fund Management Co. Ltd.	1 547 695	1 515 152	31.12.2023.
0,09928 %	GF Fund Management Co., Ltd.	1 279 000	1 279 000	30.06.2023.
0,08034 %	Penghua Fund Management Co., Ltd.	1 035 000	965 000	31.12.2023.
0,07762 %	Wu (Ting Yuk)	1 000 000	0	31.12.2022.
0,07058 %	Bessemer Trust Company, N.A. (US)	909 312	0	31.01.2024.
0,06659 %	Numeric Investors LLC	857 910	-17 182	29.02.2024.
0,05951 %	Mackenzie Financial Corporation	766 699	-2 049 575	31.12.2023.
0,05810 %	Mellon Investments Corporation	748 500	-46 500	31.03.2024.
0,05616 %	Nuveen LLC	723 500	0	31.03.2024.
0,04937 %	Asset Management One Co., Ltd.	636 000	611 500	30.11.2023.
0,04657 %	Florida State Board of Administration	600 000	600 000	30.09.2022.
0,04312 %	Avantis Investors	555 500	13 500	31.03.2024.
0,03679 %	Everbright PGIM Fund Management Co., Ltd.	474 000	474 000	30.06.2023.
0,03609 %	Geode Capital Management, L.L.C.	465 000	0	29.02.2024.
0,03105 %	Song (Qing)	400 000	0	31.12.2022.
0,02810 %	JPMorgan Asset Management (China) Company Limited.	362 000	362 000	30.06.2023.
0,02775 %	Yinhua Fund Management Co., Ltd.	357 500	357 500	31.12.2023.
0,02406 %	Margetts Fund Management Limited	310 000	310 000	31.12.2023.
0,02333 %	Segall Bryant & Hamill, LLC	300 500	0	29.02.2024.
0,02329 %	Ren (Yuan)	300 000	0	13.06.2023.
0,02088 %	Allianz Global Investors GmbH	268 951	32 500	31.01.2024.
0,01824 %	State Street Global Advisors Ireland Limited	235 000	12 000	31.03.2024.
0,01801 %	Western Leadbank Fund Management Co., Ltd.	232 000	112 000	31.12.2023.
0,01739 %	DFA Australia Ltd.	224 004	12 004	31.12.2023.
0,01265 %	Parametric Portfolio Associates LLC	163 000	0	31.01.2024.
0,01063 %	Essence Fund Management Co., Ltd.	137 000	93 500	31.12.2023.
0,00944 %	ASPOMA Asset Management GmbH	121 600	0	29.02.2024.
0,00939 %	LSV Asset Management	121 000	0	31.12.2023.
0,00910 %	JPMorgan Asset Management U.K. Limited	117 256	-23 000	31.12.2023.
0,00819 %	Huatai-PineBridge Fund Management Co., Ltd.	105 500	105 500	30.06.2023.
0,00776 %	Fullgoal Fund Management Co., Ltd.	100 000	90 500	31.12.2023.
0,00761 %	Lazard Asset Management, L.L.C.	98 000	0	31.01.2024.
0,00734 %	RAM Active Investments S.A.	94 500	94 500	31.12.2023.
0,00718 %	FIL Investment Management (Australia) Limited	92 500	92 500	29.02.2024.
0,00554 %	HSBC Global Asset Management (UK) Limited	71 400	42 000	31.01.2024.
0,00547 %	Allianz Global Investors U.S. LLC_NLE	70 500	0	31.10.2023.
0,00512 %	Ge (Lu)	66 000	66 000	14.09.2023.
0,00493 %	State Street Global Advisors (UK) Ltd.	63 500	0	29.02.2024.
0,00481 %	INVESCO Great Wall Fund Management Co. Ltd.	62 000	43 500	31.12.2023.
0,00431 %	Vanguard Global Advisers LLC	55 500	0	29.02.2024.
0,00321 %	Vanguard Investments Australia Ltd.	41 324	100	29.02.2024.
0,00268 %	Bank of Beijing Scotiabank Asset Management Co., Ltd.	34 500	34 500	30.06.2023.
0,00260 %	Lundgreen's Capital ApS	33 500	-60 000	29.02.2024.
0,00147 %	Natixis Investment Managers SA	19 000	0	31.08.2023.
0,00105 %	Irish Life Investment Managers Ltd.	13 500	0	29.02.2024.
0,00081 %	CI Global Asset Management	10 480	-699	31.03.2024.
0,00035 %	Fidelity International	4489	4489	29.02.2024.
0,00019 %	Krane Funds Advisors, LLC	2500	0	30.09.2023.
0,00019 %	BlackRock Investment Management (Australia) Ltd.	2500	0	31.12.2023.
0,00005 %	BMO Asset Management Inc.	660	0	30.11.2023.
0 %	Finlabo SIM S.p. A.	0	-50 000	29.02.2024.
0 %	Dimensional Fund Advisors Canada ULC	0	-20 500	31.07.2022.
0 %	Prudential Capital Group	0	-21 000	31.10.2022.
0 %	Ping An Fund Management Company Limited	0	-53 000	30.06.2023.
0 %	Union Investment Luxembourg S.A.	0	-431 000	30.09.2023.
0 %	CITIC Prudential Fund Management Co., Ltd.	0	-933 322	31.12.2023.
0 %	HuaAn Fund Management Co., Ltd.	0	-1 203 500	31.12.2023.
0 %	China Asset Management Co., Ltd.	0	-245 500	31.12.2022.
0 %	SEI Investments Management Corporation	0	-297 898	30.06.2023.
0 %	First Trust Advisors L.P.	0	-2 974 867	31.10.2023.
0 %	Allianz Global Investors Asia Pacific Limited	0	-134 500	31.05.2023.
0 %	Handelsbanken Kapitalförvaltning AB	0	-200 000	31.12.2022.
0 %	PGGM Vermogensbeheer B.V.	0	-12 791 942	31.07.2023.
0 %	Wilmington Trust Investment Management LLC	0	-21 000	30.09.2023.
0 %	BlackRock Financial Management, Inc.	0	-22 000	31.12.2022.
0 %	Loomis, Sayles & Company, L.P.	0	-29 000	31.12.2023.
0 %	Victory Capital Management Inc.	0	-385 000	31.12.2022.
0 %	Northern Trust Investments, Inc.	0	-24 500	31.12.2023.
0 %	PineStone Asset Management Inc.	0	-93 770	30.06.2023.

Vārds	attiecības	Divnedēļu korelācija	Vienmēneša korelācija	Trīs mēnešu korelācija	Sešu mēnešu korelācija	Viena gada korelācija	Divu gadu korelācija
UMP Healthcare Holdings	PiegādātājsKlients	0,29	0,21	0,32	0,44	0,81	0,04
Mitsubishi UFJ Financial Group	PiegādātājsKlients	-0,31	-0,10	0,30	-0,48	-0,60	-0,14

What values and corporate philosophy does China Resources Medical Holdings Company represent?

China Resources Medical Holdings Company Ltd represents values and a corporate philosophy centered on the provision of high-quality medical services and the promotion of public health in China. The company is committed to delivering accessible, efficient, and patient-centric healthcare, aiming to enhance the overall well-being of individuals and communities. China Resources Medical Holdings Company Ltd prioritizes innovation, leveraging cutting-edge technology and medical advancements to elevate the standards of healthcare delivery. With a focus on professionalism, integrity, and transparency, the company is dedicated to fostering a culture of continuous improvement in the medical field.

In which countries and regions is China Resources Medical Holdings Company primarily present?

China Resources Medical Holdings Company Ltd (CRMH) primarily operates in the Asia-Pacific region, with a focused presence in China. As a leading integrated medical service provider, CRMH has established a strong foothold in various provinces and municipalities across Mainland China. Through its extensive network, CRMH delivers comprehensive healthcare services, including medical consultations, surgeries, diagnostics, and pharmaceutical products. With a commitment to enhancing the accessibility and quality of healthcare, CRMH continually expands its presence to better serve the growing healthcare needs of the Chinese population.

What significant milestones has the company China Resources Medical Holdings Company achieved?

China Resources Medical Holdings Company Ltd has achieved several significant milestones in recent years. The company has successfully expanded its presence in the healthcare sector, becoming one of the leading integrated medical service providers in China. China Resources Medical Holdings Company Ltd has also achieved remarkable growth in terms of revenue and market share. The company has made strategic acquisitions and partnerships to enhance its capabilities and broaden its service offerings. Furthermore, China Resources Medical Holdings Company Ltd has been recognized for its commitment to quality patient care, innovative technologies, and efficient healthcare delivery. Overall, the company has shown outstanding progress and stands as a prominent player in the Chinese medical industry.

What is the history and background of the company China Resources Medical Holdings Company?

China Resources Medical Holdings Company Ltd, also known as CR Medical, is a reputable healthcare service provider in China. Established in 2005, it is a subsidiary of China Resources Corporation, a Fortune Global 500 company. With a strong focus on both medical services and pharmaceutical products, CR Medical has grown into a leading integrated healthcare group. The company operates a vast network of hospitals, clinics, and pharmacies across the country, offering a wide range of medical specialties and healthcare services to patients. Committed to promoting accessible and high-quality healthcare, China Resources Medical Holdings Company Ltd continues to expand its reach and enhance the well-being of communities it serves.

Who are the main competitors of China Resources Medical Holdings Company in the market?

Some of the main competitors of China Resources Medical Holdings Company Ltd in the market include Beijing Gehua CATV Network Co., Ltd., Shanghai RAAS Blood Products Co., Ltd., and Jiangsu Hengrui Medicine Co., Ltd.

In which industries is China Resources Medical Holdings Company primarily active?

China Resources Medical Holdings Company Ltd is primarily active in the healthcare industry.

What is the business model of China Resources Medical Holdings Company?

The business model of China Resources Medical Holdings Company Ltd focuses on providing comprehensive healthcare services in China. The company aims to offer a wide range of medical services, including hospital operations, the distribution of pharmaceutical and healthcare products, medical device manufacturing and sales, as well as healthcare management. China Resources Medical Holdings Company Ltd aims to establish a complete healthcare chain by integrating medical resources and promoting the development of high-quality healthcare services across the country. With its diverse healthcare offerings, the company strives to improve the overall well-being and medical care accessibility for individuals in China.

Kāds ir China Resources Medical Holdings Company 2024 KGV?

China Resources Medical Holdings Company KGV ir 6,29.

Kāds ir China Resources Medical Holdings Company 2024 KUV?

China Resources Medical Holdings Company KUV ir 0,37.

Kāds AlleAktien kvalitātes vērtējums ir China Resources Medical Holdings Company?

AlleAktien kvalitātes vērtējums China Resources Medical Holdings Company ir 7/10.

Cik liels ir China Resources Medical Holdings Company 2024 apgrozījums?

gaidāmā China Resources Medical Holdings Company apgrozījums ir 10,89 miljardi CNY.

Cik liels ir China Resources Medical Holdings Company 2024 peļņa?

gaidāmā China Resources Medical Holdings Company peļņa ir 639,52 milj. CNY.

Kas ir China Resources Medical Holdings Company?

China Resources Medical Holdings Company Ltd is one of the leading companies in the healthcare sector in China. The company offers a wide range of medical services and products and is divided into several divisions. The divisions of China Resources Medical Holdings include hospitals, medical facilities, diagnostic centers, as well as the sale of pharmaceuticals and medical products. The company owns and operates several hospitals and medical facilities nationwide. These provide comprehensive care for various health issues and have state-of-the-art medical equipment and technologies. In addition, the company also offers specialized services in areas such as ophthalmology, plastic surgery, and geriatrics. Furthermore, China Resources Medical Holdings operates diagnostic centers that offer a complete range of diagnostic services for patients. These include ultrasound, endoscopy, magnetic resonance imaging, and computed tomography. The company is also involved in the sale of pharmaceuticals and medical products. It distributes a wide range of products, including generic drugs, over-the-counter products, and medical devices for use in hospitals and medical facilities. Additionally, they are engaged in pharmaceutical research and development and have a strong product pipeline in various therapy areas. The company also works closely with other companies to advance research and development of new therapies. Overall, the business model of China Resources Medical Holdings is focused on meeting the needs of patients by offering a complete range of products and services to improve their health and well-being. The company places special emphasis on the quality, safety, and effectiveness of its products and services and has an excellent reputation in the industry. Given the expanding healthcare sector in China, China Resources Medical Holdings is well positioned to continue growing and increasing its market share. The company will also continue to invest in research and development and introduce new products and services to meet consumer demands.

Cik liela ir China Resources Medical Holdings Company dividende?

China Resources Medical Holdings Company izmaksā dividendes 0,12 CNY, kas tiek izmaksātas reizes gadā.

Cik bieži China Resources Medical Holdings Company maksā dividendes?

Dividendes pašlaik nevar aprēķināt China Resources Medical Holdings Company vai uzņēmums nedod dividendes.

Kas ir China Resources Medical Holdings Company ISIN?

China Resources Medical Holdings Company ISIN ir KYG2133W1087.

Kas ir China Resources Medical Holdings Company WKN?

China Resources Medical Holdings Company WKN ir A2DHMW.

Kas ir China Resources Medical Holdings Company biržas kods?

China Resources Medical Holdings Company simbols ir 1515.HK.

Cik lielu dividendēm maksā China Resources Medical Holdings Company?

Pēdējo 12 mēnešu laikā China Resources Medical Holdings Company maksāja dividendes 0,04 CNY apmērā. Tas atbilst aptuveni 1,16 % dividendes ražībai. Nākamajos 12 mēnešos China Resources Medical Holdings Company plāno maksāt dividendes 0,04 CNY apmērā.

Cik augsta ir China Resources Medical Holdings Company dividendu rentabilitāte?

China Resources Medical Holdings Company pašreizējā dividendu rentabilitāte ir 1,16 %.

Kad China Resources Medical Holdings Company maksā dividendes?

China Resources Medical Holdings Company maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos jūlijs, jūlijs, jūlijs, oktobris.

Cik droša ir China Resources Medical Holdings Company dividende?

China Resources Medical Holdings Company pēdējo 13 gadu laikā katru gadu izmaksāja dividendes.

Cik liela ir China Resources Medical Holdings Company dividende?

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 0,04 CNY. Tas atbilst dividendes ražībai 1,18 %.

Kurā sektorā atrodas China Resources Medical Holdings Company?

China Resources Medical Holdings Company tiek piešķirts nozarei "Veselība".

Wann musste ich die Aktien von China Resources Medical Holdings Company kaufen, um die vorherige Dividende zu erhalten?

Lai saņemtu pēdējo dividendu China Resources Medical Holdings Company apmērā 0,055 CNY, kas tika izmaksāta 25.10.2024., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 9.09.2024..

Kad China Resources Medical Holdings Company izmaksāja pēdējo dividendē?

Pēdējās dividendes izmaksa notika 25.10.2024..

Cik liela bija China Resources Medical Holdings Company dividende gadā 2023?

Gadā 2023, China Resources Medical Holdings Company izmaksāja 0,12 CNY dividendes.

Kādā valūtā China Resources Medical Holdings Company izmaksā dividendes?

China Resources Medical Holdings Company dividendes tiek izmaksātas CNY.

Birža	China Resources Medical Holdings Company Akciju biržas simbols
FRANKFURTE	1PH.F
HKSE	1515.HK

China Resources Medical Holdings Company Akciju biržas simbols	China Resources Medical Holdings Company FIGI
1515:HK	BBG005L6RV12
1PH:GR	BBG005NJVS87
1PH:GF	BBG005NJVS96
1PH:GS	BBG005NJVSD1
1PH:TH	BBG00C3MM319
1515EUR:EO	BBG00CTTK3X3
1515EUR:XH	BBG00CTTK407
1515EUR:XF	BBG00CTTK425
1515EUR:XE	BBG00CTTK443
1515EUR:XJ	BBG00CTTK452
1515EUR:XL	BBG00CTTK461
1515EUR:XG	BBG00CTTK470
1515EUR:XO	BBG00CTTK489
1515EUR:XS	BBG00CTTK4D3
1515EUR:XA	BBG00CTTK4F1
1515EUR:E1	BBG00CTTK4G0
1515EUR:XT	BBG00CTTK4H9
1515EUR:XW	BBG00CTTK4J7
1515EUR:XU	BBG00CTTK4K5
1515EUR:XV	BBG00CTTK4L4
1515EUR:EU	BBG00CTTK4N2
1515:H2	BBG00F135N11
1515:H1	BBG00HMKF2K0
1515EUR:XX	BBG00JN8HDS8
1515N:PO	BBG00JRFTWR4
1515N:L3	BBG00JRG0WL9
1515N:B3	BBG00JRG46R6
1515HKD:X2	BBG00JRGFZW4
1515HKD:XB	BBG00JRGFZX3
1515HKD:XH	BBG00JRGFZZ1
1515HKD:XF	BBG00JRGG014
1515HKD:XE	BBG00JRGG032
1515HKD:XJ	BBG00JRGG041
1515HKD:XL	BBG00JRGG050
1515HKD:XG	BBG00JRGG069
1515HKD:XO	BBG00JRGG078
1515HKD:XS	BBG00JRGG0C2
1515HKD:XA	BBG00JRGG0D1
1515HKD:E1	BBG00JRGG0F9
1515HKD:XT	BBG00JRGG0G8
1515HKD:XW	BBG00JRGG0H7
1515HKD:XU	BBG00JRGG0J5
1515HKD:XV	BBG00JRGG0K3
1515HKD:XM	BBG00JRGG0L2
1515HKD:XQ	BBG00JRGG0N0
1515HKD:XX	BBG00JRGG0P8
1515HKD:XZ	BBG00JRGG0Q7
1515HKD:EU	BBG00JRGG0S5
1515N:L1	BBG00Y7B11S9
1PH:LA	BBG018H99V14
1PH:LU	BBG018J2YVV6

Veic labākos ieguldījumus savā dzīvē fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Kurss

Akciju cena

Simbols1515.HK

ISINKYG2133W1087

WKNA2DHMW

China Resources Medical Holdings Company akciju kurss

Kurs

Pārskats

Intraday funkcija

Kopējais atdevē un relatīvās cenas izmaiņas

Interpretācija un ieguldījumi

China Resources Medical Holdings Company Akciju vēsture

China Resources Medical Holdings Company Akcijas apgrozījums, EBIT, peļņa KYG2133W1087 · A2DHMW

Apgrozījums, peļņa & EBIT

Apgrozījuma, EBIT un ienākumu izpratne

Gada analīze un salīdzinājumi

Ieguvumu izmantošana investīcijām

Ieguldījumu ieskati

China Resources Medical Holdings Company Apjoma, peļņas un EBIT vēsture

China Resources Medical Holdings Company Akciju Rādītāji

Peļņas un zaudējumu pārskats

Apjomi un izaugsme

Bruto marža

EBIT un EBIT marža

Ienākumi un izaugsme

Izlaistās akcijas

Gadskārtējās salīdzinājuma interpretācija

Gaidījumi un prognozes

Bilance

Bilances izpratne

Aktīvi

Parādsaistības

Pašu kapitāls

Gadu pēc gada analīze

Datu interpretācija

China Resources Medical Holdings Company akcijas maržas KYG2133W1087 · A2DHMW

Maržas

Brutomaržas izpratne

EBIT maržas analīze

Apjoma maržas ieskati

Gaidāmo vērtību interpretēšana

Salīdzinošā analīze

China Resources Medical Holdings Company Maržas vēsture

China Resources Medical Holdings Company akciju apgrozījums, EBIT, peļņa uz vienu akciju KYG2133W1087 · A2DHMW

Apjoms, EBIT un Peļņa uz vienu akciju

Apjoms uz vienu akciju

EBIT uz vienu akciju

Ienākumi uz vienu akciju

Gaidāmās vērtības

China Resources Medical Holdings Company Apjoma, peļņas un EBIT vēsture uz vienu akciju

China Resources Medical Holdings Company akcija un akciju analīze

China Resources Medical Holdings Company vērtējums pēc Fair Value

Fair Value

Fair Value izpratne

Ienākumu bāzes Fair Value

Apgrozījuma bāzes Fair Value

Dividende bāzes Fair Value

Gaidas un prognozes

Salīdzinošā analīze

China Resources Medical Holdings Company vērtējums pēc vēsturiskā PE, EBIT un P/S

China Resources Medical Holdings Company akciju skaits KYG2133W1087 · A2DHMW

Apjoms, EBIT un Peļņa uz vienu akciju

Apjoms uz vienu akciju

EBIT uz vienu akciju

Ienākumi uz vienu akciju

Gaidāmās vērtības

China Resources Medical Holdings Company Akcijas Dividende KYG2133W1087 · A2DHMW

Dividende

Pārskats par dividendēm

Interpretācija un pielietojums

Investīciju stratēģija

China Resources Medical Holdings Company Dividendu vēsture

China Resources Medical Holdings Company Akciju izmaksu attiecība KYG2133W1087 · A2DHMW

Ausschüttungsquote

Kas ir gada izmaksu kvota?

Datu interpretācija

Datu izmantošana investīcijām

China Resources Medical Holdings Company Izplatīšanas kvotu vēsture

China Resources Medical Holdings Company Peļņas prognozes

Veic labākos ieguldījumus savā dzīvē
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Simbols
1515.HK

ISIN
KYG2133W1087

WKN
A2DHMW